Bemarituzumab With Modified Folfox6 For Advanced Fgfr2-Positive Gastroesophageal Cancer: Fight Phase Iii Study Design
2019 · Future Oncology · 67 citations
https://doi.org/10.2217/fon-2019-0141
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
110
Papers
992
Citations
15
h-index
17
i10-index
Anteneh Tesfaye is an academic researcher. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Colorectal Cancer Treatments and Studies & Cancer Genomics and Diagnostics. The author has an h-index of 15, co-authored 94 publications.
ORCID: 0000-0002-7518-1825https://doi.org/10.2217/fon-2019-0141
https://doi.org/10.1007/s00280-015-2852-2
Click to start Chat